- Home
- ZYBT vs TECH Comparison
ZYBT vs TECH Comparison
Compare ZYBT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYBT
- TECH
- Stock Information
- Founded
- ZYBT 2004
- TECH 1976
- Country
- ZYBT China
- TECH United States
- Employees
- ZYBT N/A
- TECH N/A
- Industry
- ZYBT
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZYBT
- TECH Health Care
- Exchange
- ZYBT NYSE
- TECH Nasdaq
- Market Cap
- ZYBT 340.3M
- TECH 7.8B
- IPO Year
- ZYBT 2025
- TECH 1989
- Fundamental
- Price
- ZYBT $6.05
- TECH $53.14
- Analyst Decision
- ZYBT
- TECH Buy
- Analyst Count
- ZYBT 0
- TECH 11
- Target Price
- ZYBT N/A
- TECH $72.00
- AVG Volume (30 Days)
- ZYBT 357.1K
- TECH 2.2M
- Earning Date
- ZYBT 07-03-2025
- TECH 08-06-2025
- Dividend Yield
- ZYBT N/A
- TECH 0.60%
- EPS Growth
- ZYBT N/A
- TECH N/A
- EPS
- ZYBT 0.06
- TECH 0.83
- Revenue
- ZYBT $26,111,272.00
- TECH $1,208,770,000.00
- Revenue This Year
- ZYBT N/A
- TECH $7.07
- Revenue Next Year
- ZYBT N/A
- TECH $5.64
- P/E Ratio
- ZYBT $98.97
- TECH $64.02
- Revenue Growth
- ZYBT N/A
- TECH 4.72
- 52 Week Low
- ZYBT $3.50
- TECH $46.01
- 52 Week High
- ZYBT $14.30
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- ZYBT N/A
- TECH 59.96
- Support Level
- ZYBT N/A
- TECH $49.89
- Resistance Level
- ZYBT N/A
- TECH $53.95
- Average True Range (ATR)
- ZYBT 0.00
- TECH 1.89
- MACD
- ZYBT 0.00
- TECH 0.30
- Stochastic Oscillator
- ZYBT 0.00
- TECH 85.38
About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.